Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin (HA) of influenza A virus. It specifically binds to the stem fusion domain in HA2, effectively neutralizing H1, H2, H5, and H9 subtypes of influenza A viruses. This antibody is crucial for studies focused on viral entry mechanisms and the development of broad-spectrum antiviral therapies.
Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin (HA) of influenza A virus. It specifically binds to the stem fusion domain in HA2, effectively neutralizing H1, H2, H5, and H9 subtypes of influenza A viruses. This antibody is crucial for studies focused on viral entry mechanisms and the development of broad-spectrum antiviral therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
